|
Market Closed -
Other stock markets
|
Pre-market 08:50:56 am | |||
| 27.91 USD | -2.82% |
|
27.94 | +0.13% |
| 12:55am | Nordic stocks in North America, Astra Zeneca fell 1.4% | FW |
| 12:39am | Goldman Sachs raises Genmab price target to 2,350 Danish kroner (2,300), reiterates buy - BN | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 53.79B | |||||
| 54.69B | |||||
| 23.2B | - | ||||
| 23.31B | - | ||||
| 20.03B |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
